Cerebral palsy (CP) is the leading cause of motor impairment in children worldwide, presenting substantial economic burdens on families, particularly in low socio-economic settings. In India, CP affects approximately 3/1000 live births placing substantial financial and quality‑of‑life burdens on children and their caregivers. This study aimed to assess the economic burden and health-related quality of life (HRQoL) among children with CP from low economic areas in Urban Bengaluru, India. It sought to analyse the direct, indirect and non-medical costs of managing CP and evaluate the health utility index scores of affected children and their caregivers. A cross-sectional study was conducted among caregivers of children with CP in schools within Bengaluru Urban district. Data on socio-demographic, economic details, costs and HRQoL were collected through interviews using the Cost of Illness Inventory and European Quality of Life questionnaires (EQ-5D-Y for children and EQ-5D-5 L for caregivers). The study highlighted a considerable economic burden, with direct medical ₹49,498.21/$ 597.00, direct non-medical ₹4,980.36/$60.07 and indirect costs ₹64,027.61/$ 772.23. Children with CP exhibited moderate health status (HUI score: 0.6039), while caregivers reported high perceived health (HUI score: 0.9546). A significant positive correlation was observed between direct medical and non-medical costs, with negative correlations between these costs and household income, indicating higher burdens on lower-income families. This study reveals a significant economic burden on families managing CP in low socio-economic settings in Urban Bengaluru, with high direct and indirect costs. Children with CP exhibit moderate HRQoL, while caregivers maintain a high perceived health status. The findings underscore the need for targeted financial support and policy interventions to alleviate these burdens.
No takes yet. Share an insight, caveat, or question.
George et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: